How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Publishing timestamp: 2024-06-17 09:00:01
Summary
Eli Lilly's outgoing CFO discusses the company's success with weight loss and diabetes drugs, plans to ramp up manufacturing, expand patient access, and change misconceptions about obesity. She will be stepping in as the new CFO of Alphabet on July 31.
Sentiment: NEUTRAL
Tickers: GOOGL, LLY, NOVO.B-DK,
Keywords: biotechnology, novo nordisk a/s, pharmaceuticals, alphabet inc, biotech and pharmaceuticals, health care industry, eli lilly and co, business news, business,